Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

astrazeneca_plaque

AstraZeneca announces tremelimumab setback in mesothelioma test

March 1, 2016 Manufacturing and Production, Research and Development AstraZeneca, Cancer, MedImmune, tremelimumab

AstraZeneca and its global biologics research and development arm, MedImmune, have announced a setback in the result of their Phase …
News
gensight

GenSight begins Phase III retinal disease trials

February 29, 2016 Research and Development GenSight, Leber’s Hereditary Optic Neuropathy, retinal disease

French biotech GenSight has begun enrolling patients for two parallel pivotal Phase III trials with its lead candidate GS010, a …
News
eli_lilly

CHMP recommends Lilly psoriasis drug for approval

February 29, 2016 Research and Development Eli Lilly, Taltz, psoriasis

Eli Lilly’s Taltz (ixekizumab) has received a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for …
News
roche_good

Roche finds contradictory results in identical Phase III asthma trials

February 29, 2016 Manufacturing and Production, Research and Development Roche, lebrikizumab asthma

Roche has reported contradictory results from two identical Phase III studies of lebrikizumab in severe asthma, with one showing the …
News
ucb_logo

New epilepsy drug launches in UK

February 29, 2016 Medical Communications, Research and Development, Sales and Marketing Briviact, UCB Pharma, epilepsy

UCB Pharma’s Briviact (brivaracetam) has been authorised as an add-on treatment for partial onset seizures (POS), with or without secondary …
News
roche_glass_building

FDA approves Roche’s Gazyva in follicular lymphoma

February 29, 2016 Research and Development, Sales and Marketing Levact, MabThera

Strong Phase III results have seen the US FDA approve Roche’s Gazyva (obinutuzumab) plus Levact (bendamustine) chemotherapy followed by Gazyva …
News
findacure

Drug repurposing can help tackle Rare Diseases, says charity

February 29, 2016 Medical Communications, Research and Development, Sales and Marketing rare diseases

On Rare Disease Day 2016, UK charity Findacure says existing drugs may hold the key to new treatments and repurposing …
News
boehringer_good

Boehringer launches IPF initiatives

February 29, 2016 Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim, Esbriet, Roche, idiopathic pulmonary fibrosis, ofev

Boehringer Ingelheim has launched a collaborative initiative aimed at raising awareness and understanding of the rare lung disease Idiopathic Pulmonary …
News
afinitor

FDA approves new indication for Novartis’ Afinitor

February 29, 2016 Research and Development, Sales and Marketing Afinitor, Novartis

Novartis’ cancer drug Afinitor (everolimus) has been granted FDA approval in a new indication: for the treatment of adult patients …
News
eisai_logo

Eisai slams new Cancer Drugs Fund for delaying patient access

February 26, 2016 Research and Development, Sales and Marketing Cancer Drugs Fund, Eisai, Lenvima

Eisai has aimed strong criticism at NHS England for its approval of reforms to the Cancer Drugs Fund, calling the …
News
gilead-sciences

Positive CHMP opinion for Gilead’s Descovy

February 26, 2016 Research and Development Gilead Sciences

The Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the EMA, has adopted a positive opinion …
News
boehringer_good

Boehringer’s OFEV slows IPF disease progression by half in trials

February 26, 2016 Research and Development, Sales and Marketing Boehringer Ingelheim, IPF, ofev

Boehringer Ingelheim has revealed pooled analysis data from three trials, showing that its drug OFEV significantly reduces the risk of …
News

INTERVIEW: AstraZeneca on the Cancer Drugs Fund reforms

February 26, 2016 Medical Communications, Research and Development, Sales and Marketing Cancer Drugs Fund

Greg Rossi, head of the Oncology Business Unit, AstraZeneca UK and Ireland, and the company’s market access team, spoke to …
Feature

Obama announces acceleration of Precision Medicines Initiative

February 26, 2016 Medical Communications, Research and Development Obama, Precision Medicine, cancer moonshot, genomics

A year after Barack Obama announced the $200 million Precision Medicines Initiative (PMI), the US President yesterday outlined the next …
News
msd

MHRA approves new indication for MSD’s Ezetrol

February 26, 2016 Medical Communications, Research and Development, Sales and Marketing MHRA, MSD, NICE, ezetrol

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new indication for MSD’s Ezetrol (ezetimibe), making it …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026